Valdecoxib-induced systemic contact dermatitis confirmed by positive patch test

Saved in:
Bibliographic Details
Published inContact dermatitis Vol. 52; no. 1; pp. 47 - 48
Main Authors Jaeger, C., Jappe, U.
Format Journal Article
LanguageEnglish
Published Oxford, UK; Malden, USA Munksgaard International Publishers 01.01.2005
Blackwell
Subjects
Aged
allergy
Anti-Inflammatory Agents, Non-Steroidal - adverse effects
Arthritis, Rheumatoid - drug therapy
Bextra
Biological and medical sciences
cyclooxygenase-2 (COX-2) inhibitor
delayed-type hypersensitivity reaction
Dermatitis, Allergic Contact - diagnosis
Dermatitis, Allergic Contact - etiology
Drug Eruptions - diagnosis
Drug Eruptions - etiology
Drug toxicity and drugs side effects treatment
Exanthema - chemically induced
Exanthema - diagnosis
Humans
Isoxazoles - adverse effects
Male
Medical sciences
Miscellaneous (drug allergy, mutagens, teratogens...)
Patch Tests
Pharmacology. Drug treatments
Sulfonamides - adverse effects
valdecoxib
Human
Immunopathology
Prostaglandin-endoperoxide synthase
Allergy
Skin disease
cyclooxygenase-2 (COX-2) inhibitor
Enzyme
Toxicity
Enzyme inhibitor
Bextra
Cyclooxygenase 2 inhibitor
Delayed hypersensitivity
Valdecoxib
delayed- type hypersensitivity reaction
Non steroidal antiinflammatory agent
Case study
Analgesic
Contact dermatitis
Oxidoreductases
Patch
Skin test
Online AccessGet full text

Cover

More Information
Bibliography:istex:6C10C15CEB320F81E580331A2A6A26C415C25CD7
ark:/67375/WNG-W32LLB44-5
ArticleID:COD483D
ISSN:0105-1873
1600-0536
DOI:10.1111/j.0105-1873.2005.0483d.x